Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
277 studies found for:    Cerebral Atrophy
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
2 Active, not recruiting Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate
Condition: Multiple Sclerosis
Intervention:
3 Recruiting Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
Condition: Multiple Sclerosis
Intervention:
4 Completed Focal Cortical Atrophy After Myocardial Internal Capsule
Condition: Ischemic Stroke Involving Corticospinal Tract.
Intervention: Other: Additional MRI
5 Completed Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
6 Completed A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
Condition: Multiple Sclerosis
Intervention:
7 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
8 Recruiting Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic
Condition: Neuropathic Pain
Interventions: Other: stimulation on painful area (area allodynic);   Other: same stimulation on non-painful area;   Radiation: MRI scan
9 Completed Evaluation of Brain Atrophy in CIS Patients on Avonex
Condition: Multiple Sclerosis
Intervention:
10 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
11 Withdrawn A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: testosterone;   Drug: placebo gel
12 Recruiting Effect of Fingolimod on Neurodegeneration
Conditions: Cognition;   Brain Volume Loss
Intervention: Drug: 0,5 mg Fingolimod
13 Recruiting Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Conditions: Primary Progressive Multiple Sclerosis;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: Andrographolides;   Drug: placebo
14 Recruiting Aerobic Exercise and Brain Health in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Brain Atrophy;   Cognitive Impairment
Intervention: Other: Aerobic exercise
15 Not yet recruiting Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
Conditions: Atypical Alzheimer's Disease;   Logopenic Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Interventions: Drug: F-18 AV 1451;   Drug: C-11 PiB
16 Active, not recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
17 Active, not recruiting Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System;   Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Disease Progression;   Brain Atrophy
Interventions: Biological: Tcelna;   Biological: Placebo
18 Recruiting Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Condition: Cognitive Decline
Intervention:
19 Active, not recruiting Tau Imaging in Young Onset Dementia
Conditions: Alzheimer's Disease, Early Onset;   Logopenic Progressive Aphasia;   Posterior Cortical Atrophy (PCA)
Intervention: Drug: [18F]-T807 imaging tracer
20 Completed Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Interferon beta 1b

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.